Literature DB >> 16696028

Demonstration of CD44 gene expression in cells from fine needle aspirates of breast lesions by the polymerase chain reaction.

J Bolodeoku1, K Yoshida, P Yeomans, C A Wells, D Tarin.   

Abstract

Aim-To demonstrate the feasibility of studying specific gene expression in fine needle aspirates from clinical lesions. The reverse transcription/polymerase chain reaction (RT-PCR) technique was used to demonstrate CD44 gene expression in cells from diagnostic fine needle aspirates taken from patients attending the outpatient clinic for breast diseases.Methods-Polyadenylated RNA was extracted from the cells remaining in the syringe barrel after fine needle aspirate cytological diagnosis of 41 patients with breast lesions. Analysis of CD44 gene expression was performed by RT-PCR using primers flanking the site for insertion of the variant exons. The resulting products were separated on 1.2% agarose gels, transferred to nylon membranes using Southern blotting and hybridised with specific probes for standard (constitutive) and variant exons of this gene.Results-On hybridisation with the CD44 standard exon probe, the expected amplified product of approximately 482 base pairs was visualised in 22 of 41 samples examined. Further hybridisation with the "variant" exon probes (exons 7 (v2), 8 (v3), 9b (v4), 12 (v7), and 15 (v10)) on 12 of these samples showed the presence of large molecular variants in all of these samples. However, the expression pattern detected with the probes for exons 7 (v2), 8 (v3) and 9b (v4) differed among the patients.Conclusions-Expression of the standard and variant regions of the CD44 gene in cells remaining in the syringe after fine needle aspiration was demonstrated using RT-PCR. The 5' variant exon probes seemed to show different patterns of expression among the patients. Further studies are currently being conducted to determine whether there is any correlation between expression of the various components of this gene and cytological diagnosis. Using this method, it would be possible to study the expression of other candidate marker genes in breast cancer using fine needle aspirates.

Entities:  

Year:  1995        PMID: 16696028      PMCID: PMC407995          DOI: 10.1136/mp.48.6.m307

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  10 in total

1.  Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.

Authors:  D Shibata; C Almoguera; K Forrester; J Dunitz; S E Martin; M M Cosgrove; M Perucho; N Arnheim
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

Review 2.  Update on special techniques in routine cytopathology.

Authors:  I D Buley
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

3.  Detection of human papillomavirus DNA in fine-needle aspirations of metastatic squamous-cell carcinoma of the uterine cervix using the polymerase chain reaction.

Authors:  D Shibata; M Cosgrove; N Arnheim; W J Martin; S E Martin
Journal:  Diagn Cytopathol       Date:  1989       Impact factor: 1.582

4.  Diagnosis of pancreatic lesions using fine needle aspiration cytology: detection of K-ras point mutations using solid phase minisequencing.

Authors:  J Ihalainen; M Taavitsainen; T Salmivaara; A Palotie
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

5.  Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities.

Authors:  Y Matsumura; M Sugiyama; S Matsumura; A J Hayle; P Robinson; J C Smith; D Tarin
Journal:  J Pathol       Date:  1995-09       Impact factor: 7.996

6.  Significance of CD44 gene products for cancer diagnosis and disease evaluation.

Authors:  Y Matsumura; D Tarin
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

7.  Glycoprotein CD44 expression and its association with survival in breast cancer.

Authors:  H Joensuu; P J Klemi; S Toikkanen; S Jalkanen
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

8.  Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells.

Authors:  Y Matsumura; D Hanbury; J Smith; D Tarin
Journal:  BMJ       Date:  1994-03-05

9.  Alternative splicing of CD44 pre-mRNA in human colorectal tumors.

Authors:  L Finn; G Dougherty; G Finley; A Meisler; M Becich; D L Cooper
Journal:  Biochem Biophys Res Commun       Date:  1994-04-29       Impact factor: 3.575

10.  CD44 variant exon epitopes in primary breast cancer and length of survival.

Authors:  M Kaufmann; K H Heider; H P Sinn; G von Minckwitz; H Ponta; P Herrlich
Journal:  Lancet       Date:  1995-03-11       Impact factor: 79.321

  10 in total
  2 in total

Review 1.  The clinical significance of malfunction of the CD44 locus in malignancy.

Authors:  D Tarin; J Bolodeoku; S J Hatfill; T Sugino; A C Woodman; K Yoshida
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

2.  Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation.

Authors:  H Gorham; T Sugino; J Bolodeoku; K Yoshida; S Goodison; D Tarin
Journal:  Clin Mol Pathol       Date:  1996-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.